ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor

Although imatinib mesylate (IM) has transformed the treatment of gastrointestinal stromal tumors (GIST), many patients experience primary/secondary drug resistance. In a previous study, we identified a gene signature, consisting mainly of Kruppel-associated box (KRAB) domain containing zinc finger (...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rink, Lori, Ochs, Michael F., Zhou, Yan, von Mehren, Margaret, Godwin, Andrew K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556080/
https://ncbi.nlm.nih.gov/pubmed/23372733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054477
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller